Alkem becomes First Indian company to launch novel antibiotic for Multiple drug resistance (MDR) infections

Alkem (Intenza, critical care division) has announced the launch of its novel anti-infective in India under the brand name Zidavi. This is in line with company’s endeavour to ensure affordability, accessibility, and availability while saving the lives of critically ill patients. Zidavi, which is a novel combination of ceftazidime and avibactam, is recommended by the […]

Continue Reading